Condition
Metastatic Ovarian Cancer clinical trials and research
Research outlook What's coming for Ovarian cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 5 Metastatic Ovarian Cancer clinical trials that are recruiting, at sites in 3 countries (most in United States (3), Finland (1), Australia (1)). By phase: Phase 1 (2), Phase 2 (2), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Metastatic Ovarian Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| ARR-002 in advanced ovarian or endometrial cancer | Phase 1 | Orlando, Florida and 5 other locations | Recruiting | Aug 10, 2026 |
| Sacituzumab tirumotecan with or without pembrolizumab in ovarian clear cell cancer that has come back or spread | Phase 2 | Boston, Massachusetts | Recruiting | Jul 22, 2026 |
| Testing ERX-315 in patients with advanced solid tumors | Phase 1 | Ryde, New South Wales and 4 other locations | Recruiting | Aug 1, 2024 |
| Impact of Exercise and Statins on Cancer Treatment | Phase 3 | Tampere, Länsi-Suomi | Recruiting | Apr 4, 2023 |
| Immunotherapy using tumor-infiltrating lymphocytes for metastatic cancer | Phase 2 | Bethesda, Maryland | Recruiting | Aug 3, 2010 |
All recruiting trials (5)
-
ARR-002 in advanced ovarian or endometrial cancer
This phase 1 study tests ARR-002 to see if it is safe and tolerable in adults with advanced or metastatic ovarian or endometrial cancer who have limited treatment options.
-
Sacituzumab tirumotecan with or without pembrolizumab in ovarian clear cell cancer that has come back or spread
This phase II study tests Sacituzumab tirumotecan alone or with pembrolizumab in adults whose ovarian clear cell cancer has recurred or spread after prior PD-1 therapy.
-
Testing ERX-315 in patients with advanced solid tumors
This study is testing a new treatment called ERX-315 to see if it is safe and effective for people with advanced solid tumors that haven't responded to other therapies.
-
Impact of Exercise and Statins on Cancer Treatment
This study is testing if doing supervised exercise while taking cancer drugs helps people with metastatic breast, kidney, ovarian, and prostate cancer feel better and respond better to their treatment compared to exercising on their own, and if adding a cholesterol-lowering medication can make it even more effective.
-
Immunotherapy using tumor-infiltrating lymphocytes for metastatic cancer
This study is testing a new immunotherapy that uses special white blood cells from patients' tumors to see if it can help people with metastatic cancers get better, especially when combined with another treatment called pembrolizumab.
Related topics
Quick answers
How many Metastatic Ovarian Cancer clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), Finland (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.